Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.
Further investigations into the molecular actions of the 14-hydroxydihydromorphinone hydrazones (naloxazone, oxymorphazone, and naltrexazone) have suggested that their irreversible actions can be explained by the formation of their azines. These azines, naloxonazine, naltrexonazine, and oxymorphonazine, irreversibly block opiate binding in vitro 20- to 40-fold more potently than their corresponding hydrozones, naloxazone, naltrexazone, and oxymorphazone. The blockade of binding by naloxonazine shows the same selectivity for high affinity, or mu1, sites as naloxazone.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D004090:Dihydromorphine / Q000494:pharmacology; D004355:Drug Stability; D004091:Hydromorphone / Q000031:analogs & derivatives*; D007700:Kinetics; D009270:Naloxone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology; D010111:Oxymorphone / Q000031:analogs & derivatives* / Q000494:pharmacology; D011957:Receptors, Opioid / Q000187:drug effects* / Q000378:metabolism; D013329:Structure-Activity Relationship
D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone; C024224:naloxazone; C034641:naltrexazone; C034640:oxymorphazone; C034637:naltrexonazine; C034642:oxymorphonazine; C034643:naloxonazine; D010111:Oxymorphone; D004090:Dihydromorphine; D004091:Hydromorphone